Increased serum α-tocopherol acetate mediated by gut microbiota ameliorates alveolar bone loss through the STAT3 signalling pathway in diabetic periodontitis
(Journal of Clinical Periodontology; doi: 10.1111/jcpe.13862)
Miao Lu, Yanan Zhang, Xulei Yuan, Yang Zhang, Mengjiao Zhou, Tingwei Zhang, Jinlin Song
Researchers are exploring whether gut bacteria influence the substances absorbed into the blood and, in turn, inflammation around teeth. This study focused on a probiotic and compounds related to vitamin E.
Experiments involved diabetic mice with induced periodontitis, alongside human cells grown in the laboratory. Researchers tested a specific bacterial strain and vitamin E-related compounds, including an injected treatment in mice. They measured bone loss, inflammation and tissue responses.
Treated mice showed less loss of bone around teeth and changes in substances controlling bone breakdown. Cell experiments also suggested effects on inflammation and bone-forming activity. Sharing bacteria between mice supported a possible gut-related pathway. However, isolated human cells are not the same as treating people, and the experimental delivery method differs from taking a supplement.
This is early mechanistic research, not evidence that vitamin E supplements or a probiotic will repair gum damage in patients with diabetes. The original findings do not establish a human dose, safety profile or additional benefit over standard treatment. The distinction matters because a familiar nutrient can sound ready for use even when the study concerns a laboratory preparation and an experimental route of administration.
Animal and laboratory studies allow researchers to investigate processes that cannot easily be tested in people. However, experimentally induced diabetes or gum damage does not reproduce every aspect of human disease. The timing, exposure and biological responses may differ substantially. A promising effect in this setting needs further testing for both benefit and harm before it can inform patient treatment. This paper therefore helps explain a possible mechanism; it does not establish an effective human treatment or a safe dose of an experimental substance.
Read the full article Back to ResearchHosted by #diabeteschat, join Dr Varkha Rattu and the team behind the Periodontitis-Diabetes Hub for an insightful discussion exploring the importance of managing periodontitis and diabetes.
Read moreDr Antoniszczak will present a lecture about the oral health challenges among people living with diabetes. This lecture explores the key challenges faced by individuals living with diabetes, focusing on…
Read moreHosted by #diabeteschat, join Dr Varkha Rattu and the team behind the Periodontitis-Diabetes Hub for an insightful discussion exploring the importance of managing periodontitis and diabetes.
Read moreDr Antoniszczak will present a lecture about the oral health challenges among people living with diabetes. This lecture explores the key challenges faced by individuals living with diabetes, focusing on the relationship between diabetes and oral health.
Read morePeriodontitis is the 6th most prevalent condition globally
Periodontitis and diabetes are bidirectionally linked
Diabetic complications are increased if you have both diseases
Successful periodontal treatment can improve blood glucose control